Samir Malkani to Hypoglycemic Agents
This is a "connection" page, showing publications Samir Malkani has written about Hypoglycemic Agents.
Connection Strength
1.183
-
Malkani S. Are newer insulins always the better option? Curr Opin Endocrinol Diabetes Obes. 2019 04; 26(2):77-83.
Score: 0.522
-
Malkani S, Kotwal A. Frequency and Predictors of Self-Reported Hypoglycemia in Insulin-Treated Diabetes. J Diabetes Res. 2017; 2017:7425925.
Score: 0.467
-
El-Khatib FH, Balliro C, Hillard MA, Magyar KL, Ekhlaspour L, Sinha M, Mondesir D, Esmaeili A, Hartigan C, Thompson MJ, Malkani S, Lock JP, Harlan DM, Clinton P, Frank E, Wilson DM, DeSalvo D, Norlander L, Ly T, Buckingham BA, Diner J, Dezube M, Young LA, Goley A, Kirkman MS, Buse JB, Zheng H, Selagamsetty RR, Damiano ER, Russell SJ. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet. 2017 01 28; 389(10067):369-380.
Score: 0.111
-
Gealekman O, Guseva N, Gurav K, Gusev A, Hartigan C, Thompson M, Malkani S, Corvera S. Effect of rosiglitazone on capillary density and angiogenesis in adipose tissue of normoglycaemic humans in a randomised controlled trial. Diabetologia. 2012 Oct; 55(10):2794-2799.
Score: 0.082